- Home
- BCBP vs CGEN Comparison
BCBP vs CGEN Comparison
Compare BCBP & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- CGEN
- Stock Information
- Founded
- BCBP 2000
- CGEN 1993
- Country
- BCBP United States
- CGEN Israel
- Employees
- BCBP N/A
- CGEN N/A
- Industry
- BCBP Savings Institutions
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BCBP Finance
- CGEN Health Care
- Exchange
- BCBP Nasdaq
- CGEN Nasdaq
- Market Cap
- BCBP 136.5M
- CGEN 125.3M
- IPO Year
- BCBP N/A
- CGEN 2000
- Fundamental
- Price
- BCBP $8.21
- CGEN $1.81
- Analyst Decision
- BCBP Hold
- CGEN
- Analyst Count
- BCBP 2
- CGEN 0
- Target Price
- BCBP $9.50
- CGEN N/A
- AVG Volume (30 Days)
- BCBP 65.5K
- CGEN 633.3K
- Earning Date
- BCBP 10-17-2025
- CGEN 11-11-2025
- Dividend Yield
- BCBP 8.12%
- CGEN N/A
- EPS Growth
- BCBP N/A
- CGEN N/A
- EPS
- BCBP 0.19
- CGEN N/A
- Revenue
- BCBP $65,498,000.00
- CGEN $22,144,000.00
- Revenue This Year
- BCBP $23.31
- CGEN N/A
- Revenue Next Year
- BCBP $6.72
- CGEN $208.08
- P/E Ratio
- BCBP $41.25
- CGEN N/A
- Revenue Growth
- BCBP N/A
- CGEN N/A
- 52 Week Low
- BCBP $7.54
- CGEN $1.13
- 52 Week High
- BCBP $14.04
- CGEN $2.66
- Technical
- Relative Strength Index (RSI)
- BCBP 47.19
- CGEN 52.46
- Support Level
- BCBP $7.87
- CGEN $1.63
- Resistance Level
- BCBP $8.16
- CGEN $2.38
- Average True Range (ATR)
- BCBP 0.20
- CGEN 0.17
- MACD
- BCBP 0.00
- CGEN -0.04
- Stochastic Oscillator
- BCBP 55.82
- CGEN 20.67
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.